Select your country or region to view content specific to your country.
Seeplex® HPV4A ACE Screening can simultaneously detect genotype (HPV 16 and 18) and screen for 16 high-risk types and vaccine related 2 low-risk types (HPV 6/11) from patients’ cervical brush/swab, or liquid-based cytology specimen. (ex.ThinPrep®, specimen transport medium, etc.) This assay enables multiple detection of infected HPV with single specimen based on DPO™ technology.
Simultaneous HPV 16,18 genotyping and 16 high-risk HPV and HPV 6/11 screening
Useful tool for surveillance and infection control
Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies
Assistant of appropriate treatment and management for co-infection
Accurate system for result interpretation included Internal Control
A single round PCR process and 8-MOP reduces the carryover contamination risk
|1||HRC, HPV 6/11|
|2||HRC, HPV 6/11|
|7||HRC, HPV 6/11|
|8||HRC, HPV 6/11|
1~8: Clinical samples